These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 33032294)
21. Decreased Basophil Activation against House Dust Mite after Japanese Cedar Pollen Subcutaneous Immunotherapy: A Retrospective Study. Inuo C; Ando H; Tanaka K; Nakajima Y; Tsuge I; Urisu A; Kondo Y Int Arch Allergy Immunol; 2024; 185(1):73-78. PubMed ID: 37852197 [TBL] [Abstract][Full Text] [Related]
22. Efficacy and safety of sublingual immunotherapy for two seasons in patients with Japanese cedar pollinosis. Okamoto Y; Okubo K; Yonekura S; Hashiguchi K; Goto M; Otsuka T; Murata T; Nakao Y; Kanazawa C; Nagakura H; Okawa T; Nakano K; Hisamitsu M; Kaneko S; Konno A Int Arch Allergy Immunol; 2015; 166(3):177-88. PubMed ID: 25895909 [TBL] [Abstract][Full Text] [Related]
23. Long-term sublingual immunotherapy provides better effects for patients with Japanese cedar pollinosis. Hamada S; Kobayashi Y; Sakamoto D; Shimamura A; Kuroda K; Kawachi R; Kanda A; Asako M; Gotoh M; Okubo K; Tomoda K; Iwai H Auris Nasus Larynx; 2021 Aug; 48(4):646-652. PubMed ID: 33526319 [TBL] [Abstract][Full Text] [Related]
24. Inhibition of CD23-dependent facilitated allergen binding to B cells following vaccination with genetically modified hypoallergenic Bet v 1 molecules. Pree I; Shamji MH; Kimber I; Valenta R; Durham SR; Niederberger V Clin Exp Allergy; 2010 Sep; 40(9):1346-52. PubMed ID: 20604801 [TBL] [Abstract][Full Text] [Related]
25. Measurement of Japanese cedar pollen-specific IgE in nasal secretions. Sakaida H; Masuda S; Takeuchi K Allergol Int; 2014 Sep; 63(3):467-73. PubMed ID: 24957114 [TBL] [Abstract][Full Text] [Related]
26. IgG antibodies in food allergy influence allergen-antibody complex formation and binding to B cells: a role for complement receptors. Meulenbroek LA; de Jong RJ; den Hartog Jager CF; Monsuur HN; Wouters D; Nauta AJ; Knippels LM; van Neerven RJ; Ruiter B; Leusen JH; Hack CE; Bruijnzeel-Koomen CA; Knulst AC; Garssen J; van Hoffen E J Immunol; 2013 Oct; 191(7):3526-33. PubMed ID: 23997216 [TBL] [Abstract][Full Text] [Related]
27. [Lowered effectiveness of immunotherapy for cypress pollinosis by using Japanese cedar pollen extract]. Horiguchi S; Okamoto Y; Yonekura S; Okawa T; Kunii N; Yamamoto H; Sakurai D; Hanazawa T Arerugi; 2008 May; 57(5):558-61. PubMed ID: 18520178 [TBL] [Abstract][Full Text] [Related]
28. CD23 surface density on B cells is associated with IgE levels and determines IgE-facilitated allergen uptake, as well as activation of allergen-specific T cells. Selb R; Eckl-Dorna J; Neunkirchner A; Schmetterer K; Marth K; Gamper J; Jahn-Schmid B; Pickl WF; Valenta R; Niederberger V J Allergy Clin Immunol; 2017 Jan; 139(1):290-299.e4. PubMed ID: 27372566 [TBL] [Abstract][Full Text] [Related]
29. Spectrum of allergens for Japanese cedar pollinosis and impact of component-resolved diagnosis on allergen-specific immunotherapy. Fujimura T; Kawamoto S Allergol Int; 2015 Oct; 64(4):312-20. PubMed ID: 26433527 [TBL] [Abstract][Full Text] [Related]
30. Enhanced production of IgE anti-Japanese cedar pollen specific antibodies by peripheral blood B cells from patients with Japanese cedar pollinosis. Ohshima N; Hirohata S Allergol Int; 2008 Jun; 57(2):147-55. PubMed ID: 18349589 [TBL] [Abstract][Full Text] [Related]
31. Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy. Shamji MH; Ljørring C; Francis JN; Calderon MA; Larché M; Kimber I; Frew AJ; Ipsen H; Lund K; Würtzen PA; Durham SR Allergy; 2012 Feb; 67(2):217-26. PubMed ID: 22077562 [TBL] [Abstract][Full Text] [Related]
32. Different Responses in Induction of Allergen Specific Immunoglobulin G4 and IgE-Blocking Factors for Three Mite Subcutaneous Immunotherapy Products. Park KH; Lee SC; Son YW; Jeong KY; Shin YS; Shin JU; Sim da W; Park HJ; Lee JH; Lee KH; Park JW Yonsei Med J; 2016 Nov; 57(6):1427-34. PubMed ID: 27593871 [TBL] [Abstract][Full Text] [Related]
33. Long-term treatment of Japanese cedar pollinosis with Japanese cedar pollen SLIT drops and persistence of treatment effect: A post-marketing clinical trial. Nomura Y; Okubo K; Nakamura T; Sawaki S; Kitagou H; Idei N; Kaneko S; Kobayashi S; Tanaka Y; Okamoto Y Allergol Int; 2021 Jan; 70(1):96-104. PubMed ID: 32653209 [TBL] [Abstract][Full Text] [Related]
34. Effect of Japanese cedar specific immunotherapy on allergen-specific T(H)2 cells in peripheral blood. Nomura T; Tsuge I; Inuo C; Nakajima Y; Tanaka K; Naruse N; Suzuki S; Ando H; Kondo Y; Saitoh S; Urisu A Ann Allergy Asthma Immunol; 2013 May; 110(5):380-385.e1. PubMed ID: 23622011 [TBL] [Abstract][Full Text] [Related]
35. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients. Rossi RE; Monasterolo G Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445 [TBL] [Abstract][Full Text] [Related]
36. Cross-reactivity between major IgE core epitopes on Cry j 2 allergen of Japanese cedar pollen and relevant sequences on Cha o 2 allergen of Japanese cypress pollen. Miyaji K; Okamoto N; Saito A; Yasueda H; Takase Y; Shimakura H; Saito S; Sakaguchi M Allergol Int; 2016 Jul; 65(3):286-92. PubMed ID: 26916996 [TBL] [Abstract][Full Text] [Related]
37. Effects of sublingual immunotherapy on nasal symptoms and sleep disturbance in patients with Japanese cedar pollinosis. Fujii T; Kitamura Y; Kamimura S; Naito K; Takeda N Auris Nasus Larynx; 2021 Aug; 48(4):653-658. PubMed ID: 33461852 [TBL] [Abstract][Full Text] [Related]
38. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study. Horiguchi S; Tanaka Y; Uchida T; Chazono H; Ookawa T; Sakurai D; Okamoto Y Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160 [TBL] [Abstract][Full Text] [Related]
39. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide. Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093 [TBL] [Abstract][Full Text] [Related]
40. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. Scadding GW; Shamji MH; Jacobson MR; Lee DI; Wilson D; Lima MT; Pitkin L; Pilette C; Nouri-Aria K; Durham SR Clin Exp Allergy; 2010 Apr; 40(4):598-606. PubMed ID: 20184605 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]